Xiaoling Luo Selected Research

Xiaoling Luo Research Topics

Disease

24	Neoplasms (Cancer) 04/2024 - 06/2004
13	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2014
4	Choroidal Neovascularization 01/2021 - 10/2018
3	Rhabdomyosarcoma 01/2023 - 01/2018
3	Retinoblastoma (Glioblastoma, Retinal) 02/2021 - 09/2020
3	Fibrosis (Cirrhosis) 01/2021 - 11/2018
3	Lymphoma (Lymphomas) 04/2018 - 04/2015
2	Adenocarcinoma 02/2022 - 06/2004
2	Retinal Detachment (Retinal Detachments) 10/2021 - 10/2020
2	Toxocariasis 10/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 04/2021 - 10/2018
2	Ovarian Epithelial Carcinoma 01/2021 - 02/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 02/2013
1	Myopia 04/2024
1	AIDS-Related Complex (ARC) 02/2024
1	Stroke (Strokes) 10/2023
1	Cataract (Cataracts) 08/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Hyperkalemia 01/2023
1	Inflammation (Inflammations) 01/2023
1	Uremia 12/2022
1	Heart Failure 10/2022
1	Acidosis 10/2022
1	Fatigue 06/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Granuloma 10/2021
1	Macular Edema 04/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Neuroblastoma 01/2021
1	Osteoporosis 01/2021
1	Glaucoma 01/2021
1	Familial Exudative Vitreoretinopathies 01/2021
1	Blister (Bulla) 01/2021
1	Retinoschisis (Retinoschisis, Juvenile) 01/2021
1	Carcinogenesis 01/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Pterygium 12/2020
1	Atrophy 10/2020

Drug/Important Bio-Agent (IBA)

6	Retinaldehyde (Retinal)IBA 04/2024 - 10/2018
6	Proteins (Proteins, Gene)FDA Link 09/2020 - 02/2013
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
5	MicroRNAs (MicroRNA)IBA 04/2021 - 02/2013
4	Long Noncoding RNAIBA 02/2021 - 06/2020
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2018
3	trametinibIBA 01/2023 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021 - 02/2013
3	beta CateninIBA 01/2019 - 01/2017
2	KinesinsIBA 12/2023 - 02/2022
2	PotassiumIBA 01/2023 - 10/2022
2	GlypicansIBA 09/2022 - 01/2020
2	Competitive Endogenous RNAIBA 01/2021 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 10/2018
1	Nucleic AcidsIBA 04/2024
1	AlloysIBA 02/2024
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	apatinibIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Renin InhibitorsIBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	SodiumIBA 01/2023
1	CholesterolIBA 01/2023
1	ReninIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	ganitumabIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Angiotensin Receptor AntagonistsIBA 01/2023
1	ORALIT (ORS)IBA 01/2023
1	IndicanIBA 12/2022
1	Sulfates (Sulfates, Inorganic)IBA 12/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2022
1	Adenosine Triphosphatases (ATPase)IBA 02/2022
1	Epidermal Growth Factor (EGF)IBA 10/2021
1	Stromal Interaction Molecule 1IBA 10/2021
1	Cadherins (E-Cadherin)IBA 02/2021
1	AfatinibIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Vinca AlkaloidsIBA 01/2021
1	Ranibizumab (Lucentis)FDA Link 01/2021
1	ON 01910IBA 01/2021
1	Sincalide FDA Link 12/2020
1	Retinal Pigments (Pigments, Visual)IBA 09/2020
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2020

Therapy/Procedure

6	Therapeutics 04/2024 - 01/2017
3	Lasers (Laser) 10/2021 - 11/2018
2	Intraperitoneal Injections 01/2020 - 11/2018
2	Immunotherapy 04/2018 - 01/2014
1	Palliative Care (Palliative Therapy) 10/2023
1	Refractive Surgical Procedures 08/2023
1	Pancreaticoduodenectomy 02/2022
1	Slit Lamp 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Trabeculectomy (Trabeculoplasty) 01/2021
1	Treatment Delay 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021